โ† Wiki Index / Microbiology & Immunology / NLRP1 Inflammasome Activation
๐Ÿฆ  Microbiology & Immunology

NLRP1 Inflammasome Activation

NLRP1 inflammasome activation is a cytosolic innate immune pathway wherein functional degradation of an autoinhibitory amino-terminal domain unleashes a bioactive carboxyl-terminal fragment to assemble caspase-1 activating signaling platforms.

NLRP1 inflammasome activation is an intracellular sentinel mechanism that recognizes specific pathogen-encoded enzymatic activities through a mechanism termed functional degradation. NLR family pyrin domain containing 1 (NLRP1) was the founding member of the NLR family identified as assembling an inflammasome complex capable of activating inflammatory caspases. Unlike typical pattern recognition receptors that directly engage conserved microbial structural patterns through surface-exposed leucine-rich repeats, NLRP1 functions predominantly as a tripwire sensor that monitors host cell proteostasis and integrity by responding to targeted proteolytic cleavage events mediated by viral and bacterial proteases.

The human and rodent NLRP1 architectures diverge substantially, yet both share a unique bipartite arrangement containing a function-to-find domain (FIIND) and a carboxyl-terminal caspase activation and recruitment domain (CARD). Auto-cleavage within the FIIND domain generates two non-covalently associated polypeptides that remain autoinhibited under basal homeostatic conditions. Upon pathogen invasion, enzymatic modification of the amino-terminal fragment triggers its selective proteasomal degradation, liberating the bioactive carboxyl-terminal UPA-CARD fragment to nucleate polymeric ASC specks and catalyze caspase-1 activation, interleukin processing, and pyroptotic cell death.

Domain Architecture and Autoproteolysis

The primary structure of human NLRP1 encompasses an amino-terminal pyrin domain (PYD), followed by a nucleotide-binding oligomerization domain (NACHT), a series of leucine-rich repeats (LRRs), the conserved FIIND domain, and the carboxyl-terminal CARD domain. In contrast, rodent paralogs such as murine NLRP1B lack the amino-terminal PYD, demonstrating that this domain is dispensable for the downstream assembly of caspase-1 complexes in certain evolutionary lineages.

The hallmark biochemical feature of the FIIND domain is its constitutive auto-catalytic processing. FIIND contains two subdomains: a ZU5 fold (homologous to domains in ZO-1 and Unc5) and a UPA fold (conserved in Unc5, PIDD, and Ankyrin). During protein folding within the ribosome or nascent cytosolic chaperone networks, the peptide backbone undergoes spontaneous autoproteolysis at a conserved serine-phenylalanine motif (specifically Ser1213 in human NLRP1). This cleavage separates the amino-terminal polypeptide from the carboxyl-terminal UPA-CARD polypeptide.

Crucially, following autoproteolysis, the amino-terminal and carboxyl-terminal fragments do not dissociate in resting cells. Non-covalent hydrophobic and electrostatic interactions between the ZU5 and UPA folds maintain the complex in an intact, autoinhibited conformation. This association prevents spontaneous oligomerization of the CARD domain, keeping the inflammasome dormant until specific activating triggers disrupt the regulatory amino-terminal scaffold.

The Functional Degradation Mechanism

For over a decade after its discovery, the precise trigger for NLRP1 activation remained enigmatic because purified microbial ligands failed to stimulate recombinant receptor assembly in cell-free systems. Genetic and biochemical dissection in murine macrophages and human epithelial cells revealed that activation requires targeted proteasomal degradation of the amino-terminal domain.

Pathogen-derived enzymes initiate this pathway by introducing cleavages or chemical modifications near the amino terminus. For instance, the lethal factor (LF) metalloprotease secreted by Bacillus anthracis selectively cleaves the amino terminus of murine NLRP1B. In human cells, the 3C proteases encoded by picornaviruses such as enterovirus 71, coxsackievirus B3, and human rhinovirus cleave human NLRP1 within its amino-terminal linker regions.

Cleavage by these pathogen proteases exposes a neo-amino terminus that serves as an active degradation signal (degron) recognized by the ubiquitin-proteasome system via the N-end rule pathway (specifically the Arg/N-degron or Pro/N-degron arms). Ubiquitin ligases, such as UBR1 and UBR2, polyubiquitinate the destabilized amino-terminal fragment. The 26S proteasome then engages the amino terminus and progressively degrades the protein from the amino terminus toward the carboxyl terminus.

Because the polypeptide chain was previously severed at the FIIND auto-cleavage site, the 26S proteasome degrades the entire amino-terminal fragment up to the cleavage junction, at which point the non-covalently tethered carboxyl-terminal UPA-CARD fragment is physically liberated. Because the UPA-CARD fragment contains no active degron and possesses an independent folded structure, it escapes proteasomal destruction. The freed UPA-CARD polypeptide undergoes spontaneous self-oligomerization, serving as a pristine seed for downstream signaling.

ASC Polymerization and Pyroptosis Execution

Once freed from amino-terminal autoinhibition, the carboxyl-terminal UPA-CARD fragments assemble into higher-order macromolecular filaments through homotypic CARD-CARD interactions. In human cells, the liberated CARD domain can recruit the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) via homotypic interactions, leading to rapid prion-like nucleated polymerization of ASC into a micrometer-sized cytosolic focus known as the ASC speck. In some cellular contexts, murine NLRP1B CARD can recruit pro-caspase-1 directly without an absolute requirement for ASC, though ASC incorporation markedly accelerates downstream cytokine maturation.

Clustered pro-caspase-1 zymogens undergo proximity-induced dimerization and auto-proteolytic processing into active heterotetrameric p20 and p10 subunits. Active caspase-1 cleaves the inactive precursor proteins pro-interleukin-1-beta and pro-interleukin-18 into their mature, biologically active pro-inflammatory forms. Concurrently, caspase-1 cleaves the pore-forming effector protein gasdermin D (GSDMD) within its central interdomain linker.

Liberated gasdermin D amino-terminal domains translocate to the inner leaflet of the plasma membrane, where they bind phosphatidylinositol 4,5-bisphosphate and assemble into symmetric 28-subunit transmembrane pores with an inner diameter of approximately 18 nanometers. These pores allow the rapid efflux of intracellular potassium ions, the release of mature cytokines, and influx of water, driving osmotic cellular swelling, membrane rupture, and the classic form of lytic cell death known as pyroptosis.

Clinical Relevance and Therapeutic Modulation

Dysregulated NLRP1 signaling has direct clinical consequences in human infectious diseases, autoimmune disorders, and autoinflammatory syndromes. Germline gain-of-function mutations in human NLRP1 cause severe hereditary skin inflammatory conditions and cancer susceptibility syndromes, including familial keratosis lichenoides chronica and multiple self-healing palmoplantar carcinoma. Many of these pathogenic mutations map directly to the PYD or FIIND domains, where they destabilize amino-terminal autoinhibition or accelerate spontaneous amino-terminal turnover.

Conversely, pharmacologic inhibition of the serine dipeptidyl peptidases DPP8 and DPP9 using small molecules such as talabostat (Val-boroPro) triggers robust NLRP1 activation in human monocytes and acute myeloid leukemia cell lines. DPP8 and DPP9 form a ternary complex with NLRP1, stabilizing the autoinhibited resting state; displacing or inhibiting DPP8 and DPP9 triggers rapid proteasomal degradation of the amino-terminal fragment. This discovery has stimulated therapeutic interest in leveraging NLRP1 functional degradation to induce targeted pyroptotic elimination of malignant hematopoietic clones.

References

  1. Martinon, F., Burns, K., & Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell, 10(2), 417-426. doi:10.1016/S1097-2765(02)00599-300599-3)
  2. Sandstrom, A., Mitchell, P. S., Goers, L., Mu, E. W., Lesser, C. F., & Vance, R. E. (2019). Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes. Science, 364(6435), eaau1330. doi:10.1126/science.aau1330
  3. Robinson, K. S., Teo, D. E. T., Tan, K. S., Toh, G. A., Ong, H. H., Lim, C. K., ... & Reversade, B. (2020). Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia. Science, 370(6521), eaay2002. doi:10.1126/science.aay2002
๐Ÿงฌ Support Open Science
Explore interactive science games on LowKey Games or browse scientific apparel & accessories in the CRV Science Shop.
๐Ÿ’ก Spot an inaccuracy or have primary literature to expand this article?
Submit a citation or revision note using your shared CRV Science / LowKey Games profile ID.
Suggest Revision